Sodium in PDB 4w9n: Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan
Enzymatic activity of Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan
All present enzymatic activity of Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan:
2.3.1.39;
Protein crystallography data
The structure of Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan, PDB code: 4w9n
was solved by
K.H.Sippel,
N.K.Vyas,
B.Sankaran,
F.A.Quiocho,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
26.43 /
1.84
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
68.564,
75.834,
83.264,
65.38,
88.87,
65.08
|
R / Rfree (%)
|
20.6 /
23.3
|
Other elements in 4w9n:
The structure of Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan
(pdb code 4w9n). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 4 binding sites of Sodium where determined in the
Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan, PDB code: 4w9n:
Jump to Sodium binding site number:
1;
2;
3;
4;
Sodium binding site 1 out
of 4 in 4w9n
Go back to
Sodium Binding Sites List in 4w9n
Sodium binding site 1 out
of 4 in the Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na1904
b:27.8
occ:1.00
|
H
|
B:PHE1772
|
2.4
|
59.2
|
1.0
|
HD2
|
B:PHE1772
|
2.6
|
70.0
|
1.0
|
HD2
|
B:PHE1573
|
3.1
|
68.1
|
1.0
|
HB2
|
B:PHE1772
|
3.1
|
68.1
|
1.0
|
HA
|
B:ARG1574
|
3.1
|
29.9
|
1.0
|
HG3
|
B:MET1577
|
3.1
|
52.0
|
1.0
|
HA
|
B:LYS1771
|
3.2
|
39.8
|
1.0
|
N
|
B:PHE1772
|
3.2
|
49.4
|
1.0
|
O
|
B:HOH2084
|
3.3
|
36.9
|
1.0
|
HB2
|
B:ARG1574
|
3.4
|
29.9
|
1.0
|
CD2
|
B:PHE1772
|
3.5
|
58.3
|
1.0
|
HD3
|
B:LYS1771
|
3.6
|
48.3
|
1.0
|
CA
|
B:ARG1574
|
3.8
|
24.9
|
1.0
|
CB
|
B:PHE1772
|
3.8
|
56.7
|
1.0
|
HB3
|
B:PHE1573
|
3.9
|
39.1
|
1.0
|
N
|
B:ARG1574
|
3.9
|
27.5
|
1.0
|
CD2
|
B:PHE1573
|
3.9
|
56.8
|
1.0
|
CA
|
B:LYS1771
|
4.0
|
33.1
|
1.0
|
CB
|
B:ARG1574
|
4.0
|
24.9
|
1.0
|
H
|
B:ARG1574
|
4.0
|
33.0
|
1.0
|
CG
|
B:MET1577
|
4.0
|
43.3
|
1.0
|
C
|
B:LYS1771
|
4.1
|
46.5
|
1.0
|
CA
|
B:PHE1772
|
4.1
|
52.9
|
1.0
|
CG
|
B:PHE1772
|
4.1
|
55.2
|
1.0
|
HB3
|
B:LYS1771
|
4.2
|
45.4
|
1.0
|
CD
|
B:LYS1771
|
4.2
|
40.2
|
1.0
|
HG2
|
B:MET1577
|
4.2
|
52.0
|
1.0
|
HG3
|
B:ARG1574
|
4.3
|
39.6
|
1.0
|
HE
|
B:ARG1574
|
4.3
|
29.7
|
1.0
|
H
|
B:ASP1773
|
4.3
|
74.5
|
1.0
|
HE2
|
B:MET1577
|
4.4
|
67.5
|
1.0
|
C
|
B:PHE1573
|
4.4
|
31.5
|
1.0
|
HD22
|
B:LEU1583
|
4.5
|
38.3
|
1.0
|
CE2
|
B:PHE1772
|
4.5
|
51.3
|
1.0
|
HE2
|
B:PHE1772
|
4.5
|
61.5
|
1.0
|
HE2
|
B:PHE1573
|
4.5
|
73.9
|
1.0
|
CB
|
B:LYS1771
|
4.5
|
37.9
|
1.0
|
HB2
|
B:MET1577
|
4.5
|
43.2
|
1.0
|
HB3
|
B:PHE1772
|
4.6
|
68.1
|
1.0
|
CB
|
B:PHE1573
|
4.7
|
32.6
|
1.0
|
CE2
|
B:PHE1573
|
4.7
|
61.5
|
1.0
|
O
|
B:PHE1573
|
4.7
|
38.0
|
1.0
|
CG
|
B:ARG1574
|
4.7
|
33.0
|
1.0
|
CG
|
B:PHE1573
|
4.8
|
43.2
|
1.0
|
HB3
|
B:ARG1574
|
4.8
|
29.9
|
1.0
|
O
|
B:GLY1770
|
4.8
|
25.0
|
1.0
|
HA
|
B:PHE1772
|
4.9
|
63.5
|
1.0
|
CB
|
B:MET1577
|
4.9
|
36.0
|
1.0
|
N
|
B:ASP1773
|
4.9
|
62.1
|
1.0
|
HD2
|
B:LYS1771
|
4.9
|
48.3
|
1.0
|
OD1
|
B:ASP1773
|
5.0
|
77.4
|
1.0
|
C
|
B:PHE1772
|
5.0
|
57.1
|
1.0
|
|
Sodium binding site 2 out
of 4 in 4w9n
Go back to
Sodium Binding Sites List in 4w9n
Sodium binding site 2 out
of 4 in the Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Na1902
b:41.5
occ:1.00
|
HG22
|
C:VAL1699
|
2.3
|
49.2
|
1.0
|
OD1
|
C:ASN1722
|
2.4
|
54.8
|
1.0
|
HB3
|
C:PHE1720
|
2.5
|
43.4
|
1.0
|
H
|
C:ASN1722
|
2.7
|
38.2
|
1.0
|
H
|
C:VAL1699
|
3.0
|
31.2
|
1.0
|
HA
|
C:THR1698
|
3.1
|
28.2
|
1.0
|
CG2
|
C:VAL1699
|
3.3
|
41.0
|
1.0
|
HD1
|
C:PHE1720
|
3.3
|
36.5
|
1.0
|
H
|
C:ALA1721
|
3.4
|
37.5
|
1.0
|
CB
|
C:PHE1720
|
3.4
|
36.1
|
1.0
|
HA
|
C:PHE1720
|
3.4
|
39.0
|
1.0
|
OG
|
C:SER1723
|
3.5
|
75.4
|
1.0
|
N
|
C:ASN1722
|
3.5
|
31.9
|
1.0
|
HG23
|
C:VAL1699
|
3.6
|
49.2
|
1.0
|
CG
|
C:ASN1722
|
3.6
|
39.5
|
1.0
|
N
|
C:VAL1699
|
3.6
|
26.0
|
1.0
|
HG21
|
C:VAL1699
|
3.6
|
49.2
|
1.0
|
O
|
C:THR1697
|
3.6
|
22.9
|
1.0
|
N
|
C:ALA1721
|
3.7
|
31.3
|
1.0
|
CA
|
C:PHE1720
|
3.7
|
32.5
|
1.0
|
C
|
C:PHE1720
|
3.7
|
32.4
|
1.0
|
H
|
C:SER1723
|
3.8
|
57.8
|
1.0
|
N
|
C:SER1723
|
3.9
|
48.1
|
1.0
|
HG
|
C:SER1723
|
3.9
|
90.5
|
1.0
|
HG13
|
C:VAL1699
|
4.0
|
50.0
|
1.0
|
C
|
C:ASN1722
|
4.0
|
41.9
|
1.0
|
HB2
|
C:PHE1720
|
4.0
|
43.4
|
1.0
|
CA
|
C:THR1698
|
4.0
|
23.5
|
1.0
|
CD1
|
C:PHE1720
|
4.1
|
30.4
|
1.0
|
CA
|
C:ASN1722
|
4.2
|
44.1
|
1.0
|
HD3
|
C:ARG1705
|
4.2
|
69.1
|
1.0
|
CG
|
C:PHE1720
|
4.2
|
37.0
|
1.0
|
HG23
|
C:THR1697
|
4.2
|
28.6
|
1.0
|
C
|
C:THR1698
|
4.2
|
25.8
|
1.0
|
CB
|
C:VAL1699
|
4.3
|
44.8
|
1.0
|
O
|
C:PHE1720
|
4.3
|
28.3
|
1.0
|
HA
|
C:SER1723
|
4.4
|
70.5
|
1.0
|
CB
|
C:ASN1722
|
4.4
|
41.4
|
1.0
|
CB
|
C:SER1723
|
4.5
|
46.2
|
1.0
|
CA
|
C:VAL1699
|
4.5
|
38.6
|
1.0
|
C
|
C:THR1697
|
4.5
|
21.1
|
1.0
|
CA
|
C:SER1723
|
4.5
|
58.8
|
1.0
|
HD21
|
C:ASN1722
|
4.5
|
47.1
|
1.0
|
C
|
C:ALA1721
|
4.5
|
31.1
|
1.0
|
ND2
|
C:ASN1722
|
4.5
|
39.3
|
1.0
|
CG1
|
C:VAL1699
|
4.6
|
41.6
|
1.0
|
O
|
C:ASN1722
|
4.6
|
61.1
|
1.0
|
HB2
|
C:ARG1705
|
4.6
|
43.2
|
1.0
|
HB2
|
C:SER1723
|
4.6
|
55.5
|
1.0
|
CA
|
C:ALA1721
|
4.7
|
29.4
|
1.0
|
O
|
C:VAL1699
|
4.7
|
47.5
|
1.0
|
HG3
|
C:ARG1705
|
4.7
|
45.8
|
1.0
|
N
|
C:THR1698
|
4.7
|
21.0
|
1.0
|
CD
|
C:ARG1705
|
4.7
|
57.6
|
1.0
|
HG11
|
C:VAL1699
|
4.8
|
50.0
|
1.0
|
HG22
|
C:THR1698
|
4.8
|
27.4
|
1.0
|
HB3
|
C:ASN1722
|
4.8
|
49.6
|
1.0
|
HB
|
C:THR1698
|
5.0
|
31.1
|
1.0
|
|
Sodium binding site 3 out
of 4 in 4w9n
Go back to
Sodium Binding Sites List in 4w9n
Sodium binding site 3 out
of 4 in the Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 3 of Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Na1902
b:28.7
occ:1.00
|
H
|
D:GLN1714
|
2.5
|
44.9
|
1.0
|
HE21
|
D:GLN1714
|
2.6
|
70.3
|
1.0
|
HD2
|
D:PRO1713
|
2.7
|
51.0
|
1.0
|
HG3
|
D:GLN1714
|
2.7
|
64.2
|
1.0
|
HA
|
D:PHE1712
|
2.8
|
39.8
|
1.0
|
HB2
|
D:GLN1714
|
2.9
|
59.5
|
1.0
|
HD13
|
D:LEU1689
|
3.3
|
41.8
|
1.0
|
HD1
|
D:PHE1712
|
3.3
|
36.2
|
1.0
|
NE2
|
D:GLN1714
|
3.4
|
58.6
|
1.0
|
N
|
D:GLN1714
|
3.4
|
37.4
|
1.0
|
HB3
|
D:PHE1712
|
3.4
|
39.9
|
1.0
|
CG
|
D:GLN1714
|
3.4
|
53.5
|
1.0
|
CD
|
D:PRO1713
|
3.5
|
42.5
|
1.0
|
CA
|
D:PHE1712
|
3.5
|
33.2
|
1.0
|
N
|
D:PRO1713
|
3.5
|
37.5
|
1.0
|
CB
|
D:GLN1714
|
3.5
|
49.5
|
1.0
|
C
|
D:PHE1712
|
3.6
|
45.3
|
1.0
|
CD
|
D:GLN1714
|
3.8
|
56.8
|
1.0
|
CB
|
D:PHE1712
|
3.9
|
33.3
|
1.0
|
HD3
|
D:PRO1713
|
4.0
|
51.0
|
1.0
|
HE22
|
D:GLN1714
|
4.0
|
70.3
|
1.0
|
CD1
|
D:LEU1689
|
4.1
|
34.8
|
1.0
|
CA
|
D:GLN1714
|
4.1
|
37.9
|
1.0
|
CD1
|
D:PHE1712
|
4.1
|
30.1
|
1.0
|
HD12
|
D:LEU1689
|
4.1
|
41.8
|
1.0
|
HG2
|
D:GLN1714
|
4.3
|
64.2
|
1.0
|
C
|
D:PRO1713
|
4.4
|
34.7
|
1.0
|
HD11
|
D:LEU1689
|
4.4
|
41.8
|
1.0
|
HB3
|
D:GLN1714
|
4.4
|
59.5
|
1.0
|
HB2
|
D:PRO1713
|
4.4
|
51.1
|
1.0
|
O
|
D:PHE1712
|
4.4
|
33.1
|
1.0
|
CA
|
D:PRO1713
|
4.4
|
38.3
|
1.0
|
CG
|
D:PHE1712
|
4.5
|
28.1
|
1.0
|
H
|
D:LEU1715
|
4.5
|
38.1
|
1.0
|
O
|
D:ARG1711
|
4.6
|
32.6
|
1.0
|
CG
|
D:PRO1713
|
4.6
|
59.0
|
1.0
|
HA
|
D:GLN1714
|
4.7
|
45.5
|
1.0
|
CB
|
D:PRO1713
|
4.7
|
42.6
|
1.0
|
HG2
|
D:PRO1713
|
4.7
|
70.7
|
1.0
|
HB2
|
D:PHE1712
|
4.8
|
39.9
|
1.0
|
N
|
D:PHE1712
|
4.8
|
33.5
|
1.0
|
HB3
|
D:LEU1689
|
5.0
|
36.6
|
1.0
|
|
Sodium binding site 4 out
of 4 in 4w9n
Go back to
Sodium Binding Sites List in 4w9n
Sodium binding site 4 out
of 4 in the Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 4 of Enoyl-Acyl Carrier Protein-Reductase Domain From Human Fatty Acid Synthase Complexed with Triclosan within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Na1903
b:40.3
occ:1.00
|
O
|
D:HOH2050
|
2.7
|
36.9
|
1.0
|
O
|
B:HOH2041
|
2.7
|
31.6
|
1.0
|
O
|
D:HOH2016
|
2.9
|
25.5
|
1.0
|
CD2
|
D:TRP1811
|
3.0
|
29.2
|
1.0
|
CE2
|
D:TRP1811
|
3.0
|
23.8
|
1.0
|
HA
|
B:GLU1809
|
3.1
|
43.0
|
1.0
|
CE3
|
D:TRP1811
|
3.2
|
29.1
|
1.0
|
CZ2
|
D:TRP1811
|
3.2
|
28.6
|
1.0
|
HB3
|
B:ALA1812
|
3.3
|
24.0
|
1.0
|
CZ3
|
D:TRP1811
|
3.4
|
26.8
|
1.0
|
CH2
|
D:TRP1811
|
3.4
|
32.1
|
1.0
|
NE1
|
D:TRP1811
|
3.6
|
25.3
|
1.0
|
CG
|
D:TRP1811
|
3.7
|
23.6
|
1.0
|
HG3
|
B:GLU1809
|
3.7
|
41.2
|
1.0
|
HE3
|
D:TRP1811
|
3.7
|
35.0
|
1.0
|
HZ2
|
D:TRP1811
|
3.7
|
34.3
|
1.0
|
HG3
|
D:ARG1808
|
3.8
|
42.5
|
1.0
|
HA
|
D:ASP1631
|
3.9
|
30.6
|
1.0
|
HZ3
|
D:TRP1811
|
4.0
|
32.1
|
1.0
|
HB1
|
B:ALA1812
|
4.0
|
24.0
|
1.0
|
CB
|
B:ALA1812
|
4.0
|
20.0
|
1.0
|
CD1
|
D:TRP1811
|
4.0
|
25.8
|
1.0
|
HH2
|
D:TRP1811
|
4.0
|
38.5
|
1.0
|
HB2
|
B:ALA1812
|
4.0
|
24.0
|
1.0
|
CA
|
B:GLU1809
|
4.1
|
35.8
|
1.0
|
HE1
|
D:TRP1811
|
4.1
|
30.3
|
1.0
|
O
|
D:ASP1631
|
4.2
|
24.8
|
1.0
|
HB3
|
D:TRP1811
|
4.3
|
34.0
|
1.0
|
HG2
|
B:ARG1808
|
4.3
|
42.5
|
1.0
|
HB2
|
B:GLU1809
|
4.5
|
37.8
|
1.0
|
CG
|
B:GLU1809
|
4.5
|
34.3
|
1.0
|
CB
|
D:TRP1811
|
4.6
|
28.3
|
1.0
|
CB
|
B:GLU1809
|
4.6
|
31.5
|
1.0
|
O
|
B:GLU1809
|
4.6
|
35.6
|
1.0
|
HD1
|
D:TRP1811
|
4.7
|
31.0
|
1.0
|
O
|
D:HOH2008
|
4.7
|
30.7
|
1.0
|
O
|
B:ARG1808
|
4.8
|
33.8
|
1.0
|
CG
|
D:ARG1808
|
4.8
|
35.4
|
1.0
|
CA
|
D:ASP1631
|
4.8
|
25.5
|
1.0
|
N
|
B:GLU1809
|
4.8
|
31.0
|
1.0
|
C
|
D:ASP1631
|
4.9
|
25.1
|
1.0
|
C
|
B:GLU1809
|
4.9
|
24.1
|
1.0
|
HD2
|
D:ARG1808
|
4.9
|
51.7
|
1.0
|
O
|
D:HOH2048
|
4.9
|
33.2
|
1.0
|
HB2
|
D:TRP1811
|
4.9
|
34.0
|
1.0
|
HG2
|
B:GLU1809
|
4.9
|
41.2
|
1.0
|
HA
|
D:ARG1808
|
5.0
|
36.6
|
1.0
|
|
Reference:
K.H.Sippel,
N.K.Vyas,
W.Zhang,
B.Sankaran,
F.A.Quiocho.
Crystal Structure of the Human Fatty Acid Synthase Enoyl-Acyl Carrier Protein-Reductase Domain Complexed with Triclosan Reveals Allosteric Protein-Protein Interface Inhibition. J.Biol.Chem. 2014.
ISSN: ESSN 1083-351X
PubMed: 25301948
DOI: 10.1074/JBC.M114.608547
Page generated: Mon Oct 7 18:50:06 2024
|